Authors
Latest:
Pregabalin Prior Authorization and Potential Medication-Medication and Medication-Condition InteractionsThis study of patients treated with pregabalin or duloxetine found that pregabalin prior authorization policies were associated with increased exposure to potential medication-medication and medication-condition interactions.
Latest:
FDA Approves Alemtuzumab for Relapsing Forms of Multiple SclerosisThe FDA has approved alemtuzumab (Lemtrada) for the treatment of patients with relapsing forms of multiple sclerosis.
Latest:
Latent Tuberculosis After the Use of EtanerceptTNF-alpha inhibitors are used to treat a number of inflammatory conditions.
Latest:
TXNIP inhibitors: A New Class of Agents for Diabetes TreatmentTXNIP inhibition could prevent beta cell loss and protect beta cell function to potentially contribute to diabetes management and its complications.
Latest:
Value-Based Care in Specialty Populations: High-Quality Clinical Management of Home Infusion Hemophilia Patients Reduces Costs, Maintains OutcomesHigh-quality clinical management of home infusion hemophilia patients reduces costs and maintains outcomes.
Latest:
Something Has to Give: Balancing Specialty Drug Cost With ValueThe ever-growing price tag for new specialty drugs is testing the limits of the health care system to afford these revolutionary therapies.
Latest:
An Indian Health Service Ambulatory Care Resident Describes Her ExperienceAn interview with Dr. Kaley Holmstrom, an IHS Ambulatory Care Resident at the Fort Defiance Indian Hospital in Fort Defiance, AZ
Latest:
Local Health Care Partnerships Are Strongly Associated With Successful Enhanced Community Pharmacy ServicesIncorporating community pharmacists into team-based care models is recommended as a strategy for improving health care access and quality while reducing health care costs.
Latest:
How to Treat Common Skin InfectionsHelpful advice for your patients on treating bacterial skin infections.
Latest:
Elotuzumab Combination Therapy Shows Promise in Previously Treated Multiple MyelomaPatients with previously treated multiple myeloma responded well to therapy with the monoclonal antibody elotuzumab in combination with lenalidomide and low-dose dexamethasone, with a high objective response rate and longer progression-free survival (PFS) in those who received the dose being taken into phase III studies.
Latest:
Alpha-Gal (Mammalian Meat) Allergy: Implications for PharmacistsAlpha-gal, a mammalian oligosaccharide, has recently been implicated in delayed anaphylaxis reactions to mammalian meat.
Latest:
Unlocking the Data Gold Mine for Specialty PharmaciesSpecialty pharmacy needs to raise the bar in data management and be ready for tomorrow as well as deliver superior patient care.
Latest:
Emerging Therapies and the Expanding Role of Pharmacists in the Care of Patients with Heart FailureThis Continuing Education activity is supported by an educational grant from Novartis Pharmaceutical Corporation.
Latest:
The Path to Optimizing Telehealth in a Post–COVID-19 WorldThe use of these services in oncology is likely here to stay.
Latest:
Managing Hematologic Cancer Therapies and Reducing COVID-19 RiskIn this high-risk population, strategies for minimizing viral exposure during a pandemic are being considered with oncology treatment options.
Latest:
What is Death With Dignity?States are increasingly adopting this law, and pharmacists should educate and prepare themselves to keep patients informed.
Latest:
PCSK9 Inhibitors: Who are the Best Candidates for Therapy?Varying strategies among managed care organizations for PCSK9 inhibitors will shape the care of high-risk cardiovascular patients.
Latest:
Tyrosine-Kinase Inhibitors Well Tolerated, Despite Lack of Tests in Chronic Myeloid Leukemia Patients With Comorbid ConditionsChronic myeloid leukemia patients likely have comorbid conditions at the time of their diagnosis; however, most tyrosine-kinase inhibitor studies exclude patients with these conditions.
Latest:
Emphasize Medication Adherence to PatientsMethods Include Bioingestible Sensors, Motivational Interviewing, Packaging and Reminder Technology, and Synchronization
Latest:
Medicare Part D Insulin Tiering Change: Impact on Health OutcomesThis study explores the impact of a Medicare Part D formulary tier change, specifically with respect to branded insulin products, on insulin adherence, hemoglobin A1C, and diabetes-related events in elderly diabetic beneficiaries strategies for selection of appropriate and cost-effective therapy will also be discussed.
Latest:
Trends Associated with Implementing and Lifting a Pregabalin Step Therapy PolicyThis study examined the impact of a pregabalin step therapy policy on utilization and medical costs in Humana’s Medicare and commercial plans.
Latest:
Impact of Specialty Pharmacy on Treatment Costs for Rheumatoid ArthritisFor patients who use biologic treatments for rheumatoid arthritis, specialty pharmacy care yields higher medication adherence and lower medical costs than retail pharmacy care.
Latest:
Cost-Effectiveness of Medication Therapy Management in Part D Diabetic EnrolleesPharmacist-delivered medication therapy management is a cost-effective method for increasing the utilization of guideline-recommended cardiovascular therapies in high-risk diabetic Medicare patients.
Latest:
Going Beyond the Prescription in Specialty PharmacyA data-centric approach is vital for patients with complex conditions, particularly in determining what has worked well and anticipating what medical or pharmacy care is required for effective outcomes in the future.
